ClinChoice, a leading global Contract Research Organization (CRO), has announced expanding its global footprint with the acquisition of CSI Medical Research (CSI). CSI is a regional clinical CRO with professional staff and partners located across Southeast Asia (SEA), Australia and New Zealand (ANZ), to provide innovative and cost-effective clinical solutions. Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout Asia, Europe and North America around the world. CSI, incorporated in 2017, has quickly grown into a prominent regional CRO with proven track record of executing clinical trials in Southeast Asia.
Read the full article: ClinChoice Acquires CSI, Expanding Its Global Footprint into Southeast Asia //
Source: https://www.prnewswire.com/news-releases/clinchoice-acquires-csi-expanding-its-global-footprint-into-southeast-asia-302032735.html